Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,406 | 30,708 | 49,826 | 29,894 | 69,837 |
| Marketable Securities | 480,040 | 198,818 | 193,482 | 206,810 | 180,074 |
| Receivables | 5,539 | 3,948 | 3,583 | 3,916 | 3,751 |
| TOTAL | $550,049 | $236,276 | $248,397 | $242,340 | $255,677 |
| Non-Current Assets | |||||
| PPE Net | 37,223 | 33,601 | 31,066 | 8,500 | 8,347 |
| Investments And Advances | 34,182 | 4,986 | 1,012 | 16,325 | 16,343 |
| Intangibles | 1,585 | 1,585 | 1,585 | 1,585 | 1,585 |
| Other Non-Current Assets | 4,688 | 4,720 | 4,681 | 1,041 | 1,041 |
| TOTAL | $77,678 | $44,892 | $38,344 | $27,451 | $27,316 |
| Total Assets | $627,727 | $281,168 | $286,741 | $269,791 | $282,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,388 | 10,970 | 11,035 | 10,112 | 9,206 |
| Accrued Expenses | 4,346 | 3,211 | 5,479 | 4,474 | 2,909 |
| TOTAL | $75,949 | $49,390 | $44,859 | $42,943 | $41,657 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 57,215 | 35,209 | 28,345 | 28,357 | 29,542 |
| TOTAL | $163,911 | $49,413 | $53,982 | $40,196 | $47,296 |
| Total Liabilities | $239,860 | $98,803 | $98,841 | $83,139 | $88,953 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 101,674 | 101,495 | 86,339 | 84,521 | 83,611 |
| Common Shares | 1,016 | 870 | 856 | 841 | 835 |
| Retained earnings | -531,189 | -514,549 | -495,479 | -482,388 | -470,034 |
| Other shareholders' equity | -157 | -385 | -286 | -131 | -143 |
| TOTAL | $387,867 | $182,365 | $187,900 | $186,652 | $194,040 |
| Total Liabilities And Equity | $627,727 | $281,168 | $286,741 | $269,791 | $282,993 |